5879 - Psychiatry: Research (Answered)

Dr Poulter
To ask the Secretary of State for Health, pursuant to the Answer of 24 June 2015 to Question 3297, what funds his Department has provided for psychotherapy research (a) in cash terms, (b) in real terms and (c) as a proportion of the total research and development budget in each year since 2002.

George Freeman

5878 - Mental Illness: Veterans (Answered)

Dr Poulter
To ask the Secretary of State for Health, pursuant to the Answer of 24 June 2015 to Question 3297, what funds his Department has provided for research into veterans' mental health (a) in cash terms, (b) in real terms and (c) as a proportion of the total research and development budget in each year since 2002.

George Freeman

5877 - Learning Disability: Research (Answered)

Dr Poulter
To ask the Secretary of State for Health, pursuant to the Answer of 24 June 2015 to Question 3297, what funds his Department has provided for mental health and psychiatric research relating to learning disabilitiues (a) in cash terms, (b) in real terms and (c) as a proportion of the total research and development budget in each year since 2002.

George Freeman

5883 - Scleroderma: Health Education (Answered)

Mr Douglas Carswell
To ask the Secretary of State for Health, what steps his Department is taking to promote awareness of scleroderma to health professionals and the wider public.

George Freeman

There are between 5,000 and 8,000 rare diseases. Each one affects less than 0.1% of the United Kingdom’s population, but together affect the lives of 3 million people making considerable demands on the resources and capacity of the National Health Service and other care services.

5806 - NHS England: Correspondence (Answered)

Greg Mulholland
To ask the Secretary of State for Health, when he expects Simon Stevens to reply to the letter of 30 June 2015 from Jayne Spink of the Tuberous Sclerosis Association.

George Freeman

The office of the Chief Executive at NHS England has confirmed that the letter from Jayne Spink dated 30 June 2015 has been received and noted. It is not routine practice for him to respond to correspondence to which he has been copied.

6051 - Morquio Syndrome: Drugs (Answered)

Mr Gregory Campbell
To ask the Secretary of State for Health, if he will approve the use of Vimzin as an enzyme replacement therapy for Morquio on an interim basis until NICE makes a final decision in October 2015.

George Freeman

My Rt. hon. Friend the Secretary of State does not make decisions on the approval of drugs for treatment on the National Health Service.

5872 - Everolimus (Answered)

Greg Mulholland
To ask the Secretary of State for Health, what discussions he has had with NHS England and NICE on the timescale for approving a commissioning policy for Everolimus.

George Freeman

6130 - Morquio Syndrome: Drugs (Answered)

Greg Mulholland
To ask the Secretary of State for Health, what assessment he has made of the compatibility of NHS England's announcement on 2 July 2015 on a final funding decision on Vimizim with the EU directive on transparency of measures regulating the prices of medicinal products for human use.

George Freeman

5876 - Psychiatry: Research (Answered)

Dr Poulter
To ask the Secretary of State for Health, pursuant to the Answer of 24 June 2015 to Question 3297, what funds his Department has provided for forensic psychiatric research (a) in cash terms, (b) in real terms and (c) as a proportion of the total research and development budget in each year since 2002.

George Freeman

5745 - Oilseed Rape: Allergies (Answered)

Mike Weir
To ask the Secretary of State for Health, what estimate he has made of the cost of prescription drugs to treat (a) oilseed rape allergy syndrome and (b) conditions displaying symptoms consistent with oilseed rape allergy syndrome in each year since 2010.

George Freeman

Information is not collected centrally on the number of people prescribed medicines or the medical condition being treated.

Pages